140 related articles for article (PubMed ID: 35284762)
1. Nanoencapsulation as a Promising Platform for the Delivery of the Morin-Cu(II) Complex: Antibacterial and Anticancer Potential.
Ghosh P; Bag S; Parveen S; Subramani E; Chaudhury K; Dasgupta S
ACS Omega; 2022 Mar; 7(9):7931-7944. PubMed ID: 35284762
[TBL] [Abstract][Full Text] [Related]
2. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
[TBL] [Abstract][Full Text] [Related]
3. Complexation With Human Serum Albumin Facilitates Sustained Release of Morin From Polylactic-Co-Glycolic Acid Nanoparticles.
Ghosh P; Patwari J; Dasgupta S
J Phys Chem B; 2017 Mar; 121(8):1758-1770. PubMed ID: 28201869
[TBL] [Abstract][Full Text] [Related]
4. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
5. Cell cytotoxicity and serum albumin binding capacity of the morin-Cu(ii) complex and its effect on deoxyribonucleic acid.
Roy AS; Samanta SK; Ghosh P; Tripathy DR; Ghosh SK; Dasgupta S
Mol Biosyst; 2016 Aug; 12(9):2818-33. PubMed ID: 27345944
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of morin in lipid core/PLGA shell nanoparticles significantly enhances its anti-inflammatory activity and oral bioavailability.
Sunoqrot S; Alkurdi M; Al Bawab AQ; Hammad AM; Tayyem R; Abu Obeed A; Abufara M
Saudi Pharm J; 2023 Jun; 31(6):845-853. PubMed ID: 37228320
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
8. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
9. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of sunscreen creams containing morin-encapsulated nanoparticles for enhanced UV radiation protection and antioxidant activity.
Shetty PK; Venuvanka V; Jagani HV; Chethan GH; Ligade VS; Musmade PB; Nayak UY; Reddy MS; Kalthur G; Udupa N; Rao CM; Mutalik S
Int J Nanomedicine; 2015; 10():6477-91. PubMed ID: 26508854
[TBL] [Abstract][Full Text] [Related]
11. Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization.
Lomis N; Westfall S; Farahdel L; Malhotra M; Shum-Tim D; Prakash S
Nanomaterials (Basel); 2016 Jun; 6(6):. PubMed ID: 28335244
[TBL] [Abstract][Full Text] [Related]
12. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
14. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
15. Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study.
Li XY; Xu L; Li HL; Du J; Liu XS; Li FH
Mol Med Rep; 2018 Mar; 17(3):3763-3768. PubMed ID: 29286171
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
18. Development, Characterization, and Evaluation of α-Mangostin-Loaded Polymeric Nanoparticle Gel for Topical Therapy in Skin Cancer.
Md S; Alhakamy NA; Neamatallah T; Alshehri S; Mujtaba MA; Riadi Y; Radhakrishnan AK; Khalilullah H; Gupta M; Akhter MH
Gels; 2021 Nov; 7(4):. PubMed ID: 34842729
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.
Sanna V; Siddiqui IA; Sechi M; Mukhtar H
Mol Pharm; 2013 Oct; 10(10):3871-81. PubMed ID: 23968375
[TBL] [Abstract][Full Text] [Related]
20. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
